Information for COPD Support groups  for the benefit of the COPD patient
Home   FAQ Contact  
 

COPD Council
131 DW Highway #627
Nashua, NH 03060
 

Email Addresses:

Webmaster: Webmaster@COPDCouncil.org

Calendar Information: Events@COPDCouncil.org

Speaker Information: Speakers@COPDCouncil.org

Print this Page


  

Check here for all
the latest COPD
related news


   Latest Event News

NEWS RELEASE RIDGEFIELD, CT (February 2, 2004) -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has approved Spiriva® HandiHaler® (tiotropium bromide inhalation powder) for the long-term, once-daily maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD). see news release at:
http://www.pfizer.com/are/news_
releases/2004pr/mn_2004_0202.html.



Copyright 2003-2011 COPDCouncil.org